- Home
- BDSX vs VRCA Comparison
BDSX vs VRCA Comparison
Compare BDSX & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- VRCA
- Stock Information
- Founded
- BDSX 2005
- VRCA 2013
- Country
- BDSX United States
- VRCA United States
- Employees
- BDSX N/A
- VRCA N/A
- Industry
- BDSX Precision Instruments
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- BDSX Health Care
- VRCA Health Care
- Exchange
- BDSX Nasdaq
- VRCA Nasdaq
- Market Cap
- BDSX 53.2M
- VRCA 58.7M
- IPO Year
- BDSX 2020
- VRCA 2018
- Fundamental
- Price
- BDSX $0.43
- VRCA $5.06
- Analyst Decision
- BDSX Strong Buy
- VRCA Hold
- Analyst Count
- BDSX 5
- VRCA 5
- Target Price
- BDSX $1.75
- VRCA $60.00
- AVG Volume (30 Days)
- BDSX 4.2M
- VRCA 48.8K
- Earning Date
- BDSX 10-31-2025
- VRCA 11-03-2025
- Dividend Yield
- BDSX N/A
- VRCA N/A
- EPS Growth
- BDSX N/A
- VRCA N/A
- EPS
- BDSX N/A
- VRCA N/A
- Revenue
- BDSX $76,556,000.00
- VRCA $14,704,000.00
- Revenue This Year
- BDSX $18.80
- VRCA $264.34
- Revenue Next Year
- BDSX $27.76
- VRCA $33.95
- P/E Ratio
- BDSX N/A
- VRCA N/A
- Revenue Growth
- BDSX 25.70
- VRCA 5.72
- 52 Week Low
- BDSX $0.17
- VRCA $3.82
- 52 Week High
- BDSX $1.88
- VRCA $20.90
- Technical
- Relative Strength Index (RSI)
- BDSX 52.94
- VRCA 35.28
- Support Level
- BDSX $0.41
- VRCA $4.91
- Resistance Level
- BDSX $0.54
- VRCA $5.39
- Average True Range (ATR)
- BDSX 0.04
- VRCA 0.39
- MACD
- BDSX -0.00
- VRCA -0.05
- Stochastic Oscillator
- BDSX 30.90
- VRCA 9.44
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.